Select a Region North America


Christine Malmberg

Vice President, Market Access and Pricing


Consulting (Strategy Management & Regulatory), Market Access, Payers, Pricing, Reimbursement & Market Access, Project Management, Rare Disease, RWE

Christine is a former hospital-based clinician who has worked as a market access consultant to the Canadian pharma industry for over 15 years.  She has substantial knowledge of the Canadian reimbursement environment, having gained extensive “hands-on” experience developing clinical and economic submission documents for CADTH, INESSS, private payers, provinces, and hospitals.

Ensuring dossiers are aligned with business strategy while effectively arguing unmet clinical need and place in therapy, Christine has worked on and/or led numerous successful drug submissions in all manner of therapeutic areas, including oncology and rare diseases.

As operations and clinical lead within Market Access and Pricing at EVERSANA, Christine supports project teams to ensure clients efficiently and successfully navigate the complex and rigorous Canadian HTA process. She is also passionate about mentoring newer market access professionals.

Christine is a licensed pharmacist in British Columbia with a bachelor of pharmacy degree from the University of British Columbia and a doctor of pharmacy degree from the University of Toronto.

Articles by Christine Malmberg

Navigating an Ever-evolving Canadian Market Access and Reimbursement Environment

These are just some of the trends currently shaping the Canadian market access environment. Achieving favourable market access and reimbursement outcomes for new treatments in this ever-changing landscape requires intimate knowledge of the Canadian landscape, processes and key stakeholders, careful strategic planning, sound tactics and skilled execution. Some key steps and considerations to maximize the […]

Interested in scheduling a meeting or speaking event?

Contact Us